SII to launch QHPV vaccine against cervical cancer Rahul Verma14 July 2022 10:42 AM ISTIndia's first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer gets Drugs Controller General of India's (DCGI) approval for...
Covishield demand down under Covax Rahul Verma13 July 2022 3:07 PM ISTAs per a document on the World Health Organization (WHO)- supported global Covid vaccine facility, Serum Institute of India's COVID vaccine...
FIRST: Serum Institute gets DCGI nod for qHPV vaccine against cervical cancer Ruchika Sharma13 July 2022 11:37 AM ISTThe National Technical Advisory Group on Immunisation (NTAGI) had recently also approved the qHPV after reviewing the clinical trial data of the...
NTAGI to discuss data of Gennova Pharma mRNA vaccine against COVID Ruchika Sharma12 July 2022 1:00 PM ISTThe indigenous innovative mRNA vaccine is based on the second wave driven by the Delta variant and can be kept under 2 to 8 degrees Celsius this means...
DCGI recommends allowing Serum Institute to manufacture, stockpile QHPV vaccine Rahul Verma8 July 2022 5:30 PM ISTThe Drugs Controller General of India has recommended allowing Serum Institute of India to manufacture and stockpile their life-saving qHPV vaccine...
DCGI recommends allowing SII to manufacture, stockpile life-saving qHPV vaccine against cervical cancer Ruchika Sharma7 July 2022 1:30 PM ISTCervical cancer is the second-most frequent type of the disease in India among women aged between 15 and 44 years.
Include Cy-Tb injection in national TB elimination programme: SII urges MoHFW Ruchika Sharma5 July 2022 1:21 PM ISTNew Delhi: Serum Institute has requested the Union health ministry for inclusion of their Cy-Tb injection for detection of Latent-TB in the National...
Serum Institute seeks Covovax inclusion in COVID vaccination program Ruchika Sharma30 Jun 2022 1:00 PM IST“Even employees of our firm, who have relentlessly worked on this life-saving vaccine, are requesting to us to provide this life-saving vaccine for...
COVID-19: DCGI nod to Gennova's indigenous mRNA vaccine for emergency use in 18 years and above; SII's Covovax for 7-11 years Ruchika Sharma29 Jun 2022 10:00 AM ISTGennova developed the mRNA vaccine with the support of the Department of Biotechnology (DBT) under the Ministry of Science and Technology and its PSU,...
Govt advisory panel to review trial data on Serum Institute qHPV vaccine against cervical cancer Ruchika Sharma27 Jun 2022 11:29 AM ISTNew Delhi: The government advisory panel NTAGI is likely to review on June 28 trial data on India's first quadrivalent human papillomavirus (qHPV)...
CDSCO panel recommends emergency use nod for SII Covovax for kids aged 7 to 11 years Ruchika Sharma25 Jun 2022 12:45 PM ISTThe recommendation has been sent to Drugs Controller General of India (DCGI) for final approval.
CDSCO panel recommends market nod for Serum Institute qHPV vaccine against cervical cancer Ruchika Sharma16 Jun 2022 1:45 PM ISTIn the application, Singh is learnt to have stated that qHPV vaccine CERVAVAC has demonstrated robust antibody response that is nearly 1,000 times...
